Zheng-Pin Wang

Title: Innovations of Zheng-Pin Wang in Cancer Cell Enrichment

Introduction

Zheng-Pin Wang is a notable inventor based in Towson, MD (US). He has made significant contributions to the field of cancer research, particularly in the enrichment of rare cells. His innovative methods aim to improve the detection and analysis of cancer cells in bodily fluid samples.

Latest Patents

Zheng-Pin Wang holds a patent for a method of enriching rare cells, specifically cancer cells such as prostate cancer cells. The patent describes a comprehensive process that includes obtaining a sample containing both cancer cells and non-rare cells. The method involves multiple density gradient separations to produce fluids with increased concentrations of cancer cells. This innovative approach enhances the ability to isolate and study cancer cells, which is crucial for advancing cancer diagnostics and treatment.

Career Highlights

Wang is affiliated with Johns Hopkins University, where he continues to engage in groundbreaking research. His work has the potential to significantly impact cancer treatment methodologies and improve patient outcomes. With a focus on rare cell enrichment, he is at the forefront of developing techniques that could revolutionize cancer diagnostics.

Collaborations

Zheng-Pin Wang has collaborated with esteemed colleagues such as Paul O Ts'o and Stephen A Lesko. These partnerships highlight the collaborative nature of research in the field of cancer and the importance of teamwork in driving innovation.

Conclusion

Zheng-Pin Wang's contributions to cancer research through his patented methods of enriching rare cells demonstrate his commitment to advancing medical science. His work at Johns Hopkins University and collaborations with other researchers underscore the importance of innovation in the fight against cancer.